Tripterygium wilfordii whole
- Generic Name
- Tripterygium wilfordii whole
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- GBE347P41D
- Background
Tripterygium wilfordii whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Associated Conditions
- -
- Associated Therapies
- -
Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-07-18
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 504
- Registration Number
- NCT03589833
- Locations
- 🇨🇳
Deptment of Rheumatology, Peking Union Medical College Hospital, Beijing, Beijing, China
Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-07-13
- Last Posted Date
- 2014-06-02
- Lead Sponsor
- Zhi-Hong Liu, M.D.
- Target Recruit Count
- 100
- Registration Number
- NCT01161459
- Locations
- 🇨🇳
Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China
Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis
Phase 2
- Conditions
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2009-04-29
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 80
- Registration Number
- NCT00889694
To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2011-05-18
- Lead Sponsor
- Nanjing University School of Medicine
- Target Recruit Count
- 94
- Registration Number
- NCT00881309
- Locations
- 🇨🇳
Research Institute of Nephrology,Jinling Hospital, Nanjing, Jiangsu, China
Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-12-03
- Last Posted Date
- 2015-03-30
- Lead Sponsor
- Zhi-Hong Liu, M.D.
- Target Recruit Count
- 300
- Registration Number
- NCT00801268
- Locations
- 🇨🇳
Liu ZH, Yao XD,Chen X,Hu YL, Nanjing, Jiangsu, China
🇨🇳Yao Xiaodan, Nanjing, Jiangsu, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath